$<p>Adjusted for study, gender and age. Not for cervical disease where only women were included.</p>&<p>Further adjusted for education, physical activity, smoking habits, alcohol intake, body mass index, systolic and diastolic blood pressure, serum triglycerides and HDL-cholesterol.</p><p><sup>*</sup> HPV-related cancers include cancer, cervix (ICD-7: 1711, 1712, ICD-10: C53), cancer, head and neck, subset (ICD-7: 1410, 1411, 1418, 1450, 1442, 1458, 1480, ICD-10: C01.9, C02.4, C02.8, C09.0, C09.1, C09.8, C09.9, C10.2, C10.8, C10.9, C14.0, C14.2, C14.8), cancer, vulva and vagina (ICD-7: 1760, 1761, 1762, 1763, 1765, ICD-10: C51, C52), cancer, penis (ICD-7: 1790, ICD-10: C60), and cancer, anus (ICD-7: No sufficiently specific ICD-7 code, ICD-...
<p>Footnotes to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0038731#pone-0...
Background: In human papillomavirus (HPV)-based cervical screening programs, management of HPV-posit...
Non-16/18 HRHPV infections contributed to 95% (7.9% of 8.3%) of the overall HRHPV prevalence in 2019...
<p>Complete case analysis. Persons suffering from the cancer or disease of interest at baseline were...
<p><sup>*</sup> HPV-related cancers include cancer, cervix (ICD-7: 1711, 1712, ICD-10: C53), cancer,...
<p>Odds ratios and 95% confidence intervals for top-ranked SNPs (p≤0.0001) with either an associatio...
<p>CIs: Confidence Intervals.</p><p>CIN: Cervical Intra-Epithelial Neoplasia.</p><p>HR: High-Risk ge...
<p>The prevalence rates of different HPV genotypes in 265 women with HPV-positive and cytology-negat...
<p><sup>1</sup> Alpha-9 species includes HPV-16, -31, -33, -35, -52, -58, and -67</p><p><sup>2</sup>...
a<p>Patient group ≤40 yrs was taken as reference group and odds ratios were calculated using a logis...
Background: Cervical-uterine cancer (CaCu) is the second leading cause of death in women worldwide a...
Mounting evidence supports incorporation of HPV testing into cervical screening; however, the optima...
<p>Ab = antibody; OR = odds ratio; CI = confidence interval; MSW = men who have sex with women only....
International audienceBackgroundMucosal human papillomavirus (HPV) infection is a necessary cause of...
HUMAN PAPILLOMAVIRUS(HPV) is estimated to be themost common sexuallytransmitted infection in the Uni...
<p>Footnotes to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0038731#pone-0...
Background: In human papillomavirus (HPV)-based cervical screening programs, management of HPV-posit...
Non-16/18 HRHPV infections contributed to 95% (7.9% of 8.3%) of the overall HRHPV prevalence in 2019...
<p>Complete case analysis. Persons suffering from the cancer or disease of interest at baseline were...
<p><sup>*</sup> HPV-related cancers include cancer, cervix (ICD-7: 1711, 1712, ICD-10: C53), cancer,...
<p>Odds ratios and 95% confidence intervals for top-ranked SNPs (p≤0.0001) with either an associatio...
<p>CIs: Confidence Intervals.</p><p>CIN: Cervical Intra-Epithelial Neoplasia.</p><p>HR: High-Risk ge...
<p>The prevalence rates of different HPV genotypes in 265 women with HPV-positive and cytology-negat...
<p><sup>1</sup> Alpha-9 species includes HPV-16, -31, -33, -35, -52, -58, and -67</p><p><sup>2</sup>...
a<p>Patient group ≤40 yrs was taken as reference group and odds ratios were calculated using a logis...
Background: Cervical-uterine cancer (CaCu) is the second leading cause of death in women worldwide a...
Mounting evidence supports incorporation of HPV testing into cervical screening; however, the optima...
<p>Ab = antibody; OR = odds ratio; CI = confidence interval; MSW = men who have sex with women only....
International audienceBackgroundMucosal human papillomavirus (HPV) infection is a necessary cause of...
HUMAN PAPILLOMAVIRUS(HPV) is estimated to be themost common sexuallytransmitted infection in the Uni...
<p>Footnotes to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0038731#pone-0...
Background: In human papillomavirus (HPV)-based cervical screening programs, management of HPV-posit...
Non-16/18 HRHPV infections contributed to 95% (7.9% of 8.3%) of the overall HRHPV prevalence in 2019...